Peripheral artery disease
New - Data from the Imperial Clinical Program demonstrates ELUVIA moreeffective in diabetic patients January 22, 2019
Boston Scientific today announced diabetic
subanalysis results from the IMPERIAL trial in which patients treated with the ELUVIA™ Drug-Eluting Vascular Stent System demonstrated statistically significant lower rates of...
READ MORE
Boston Scientific Announces Favorable Twelve-Month Data for Ranger™ Paclitaxel-Coated PTA Balloon Catheter - April 25, 2017
Boston Scientific today announced results from the RANGER SFA trial for the Ranger™ Paclitaxel-Coated PTA Balloon Catheter at the ...
SEE ALL PRESS RELEASES
